Raphael C Wong, 7770 Shadowbrook, Irvine, CA 92604

6627152, Sep 30, 2003

Jul 20, 2000

09/620347

Raphael C. Wong - Irvine CA

Branan Medical Corp. - Irvine CA

G01N 2100

422 58, 422 55, 422 56, 422 57, 422 61, 422 681, 422100, 422102

A fluid testing apparatus comprises a vessel for collecting a fluid, a removable cap secured to the top of the vessel, and a movable carrier to transport a portion of the fluid in the vessel to test strips disposed within the cap. The test strips are disposed in cavities of the cap. One end portion of each test strip exits through an exit port on the bottom side of the cap. A rim on the bottom side of the cap surrounds the protruding end portions of the test strips. The movable carrier is movable between a retrieving position to collect the fluid and a testing position where the retrieved fluid is brought into contact with the protruding ends of the test strips. A spring bias mechanism causes the carrier to move toward the closed, testing position by default. In the testing position, the carriers receptacle forms a seal with the surrounding rim and the bottom side of the cap to prevent the carried portion of the fluid from contacting the remaining, non-tested fluid in the vessel. A method for containing and testing a fluid is also provided.

6818452, Nov 16, 2004

Apr 23, 2001

09/840566

Raphael C. Wong - Irvine CA

Branan Medical Corp. - Irvine CA

G01N 3348

436169, 436135, 436128, 436816, 436901, 422 58, 422 61

A test strip assembly for detecting the presence of a substance in liquid sample comprises a contact detection pad in communication with a reagent-free absorbent strip. The absorbent strip receives the liquid sample and communicates it to the contact detection pad via lateral flow. The absorbent strip and contact detection pad are adhered to a support. A liquid impermeable pad is disposed adjacent to and spaced apart from the contact detection pad to prevent any further travel of the sample. Further add-on assemblies may be coupled to the base test strip assembly. The test strip assembly may be disposed in a housing along with a drug test strip to form a device that performs multiple types of tests. Methods for assaying and manufacturing are also provided.

6875185, Apr 5, 2005

Jul 29, 2002

10/208574

Raphael C. Wong - Irvine CA, US
Dequn Wang - San Diego CA, US

Branan Medical Corporation - Irvine CA

A61B005/00
B65D081/00

600584, 422 58, 422 99

A lateral flow immunoassay contact chemical test device and method integrates sample collection, prescreen testing, and confirmation sample collecting and storing with a single device and a minimum of steps. While particularly advantageously used with an oral fluid sample absorbed directly from a person's mouth, (in which constant monitoring of a collection process is made possible), the test device may be used with any of a variety of sample fluids. Prescreen testing and confirmation testing are performed on a single sample. Prescreen testing is performed by a lateral flow assay. The sample collection pad is subsequently separated from the wicking path to prevent continued migration from, and backflow into the sample collection pad, so that the confirmation sample is preserved in the sample collection pad. A multitude of antigens can be detected with a single device.

7981382, Jul 19, 2011

Jun 14, 2005

11/153732

Raphael C. Wong - Irvine CA, US
Ker-Kong Tung - Del Mar CA, US

Branan Medical Corporation - Irvine CA

G01N 33/00

422401, 422402, 422408, 422417, 422 681, 422561

A device for collecting, testing and storing fluids includes a container and a removable cap. Body fluids, such as urine, are collected in the container. The cap defines a test strip holder that receives one or more drug test strips and an adulteration strip. An opening defined through a bottom of the cap provides fluid communication between the container and the cap. When tilted, fluid from the container enters the cap through the hole. A variety of plugs may be employed to block the opening and thereby prevent fluid communication between the container and the cap after fluid has entered the cap. The remaining uncontaminated and untested body fluid is stored in the container and thus made available for further confirmation testing. Associated methods for collecting, testing and storing fluids with a single device are also provided. A method of manufacturing the foregoing test device is also provided.

2002013, Sep 19, 2002

Mar 16, 2001

09/810783

Raphael Wong - Irvine CA, US

G01N033/53
C12M001/34

435/007100, 435/287200

A combination drug test and adulterant test device comprises a container having an adulterant test strip and a drug test strip. The strips are held in place and kept physically and fluidly separate from each other by a combination of recesses, ribs, and uneven surfaces. Apertures are formed in the upper portion of the body for providing access to the strips to enable portions of the sample to be disposed. Windows are formed in the upper portion for viewing the indicator portions of the drug test strips. A method for manufacturing drug test strips is also provided.

2006000, Jan 12, 2006

Jul 9, 2004

10/888029

Raphael Wong - Irvine CA, US
Richard Zoltek - North Webster IN, US

G01N 33/558

436514000

A test apparatus that allows testing for the presence of both drugs of abuse and alcohol within a single device. In general, the apparatus of the present invention includes a lateral flow immunoassay screening for various drugs of abuse and a reactive pad including an enzyme as a test for alcohol. The two types of tests are contained within the same housing and these tests are performed using the same sample source from a subject being tested.

2011004, Feb 24, 2011

Aug 11, 2010

12/854812

Raphael Wong - Irvine CA, US
Wen Li - Los Angeles CA, US

BRANAN MEDICAL CORPORATION - Irvine CA

G01N 33/52

422 69

A drug test device for bodily fluids, such as urine, includes a cup and a removable lid which houses one or more test strips. The lid is releasably locked onto the cup so as to align dipping ends of the test strips exposed through an underside of the lid with a position stabilizer, thereby causing the dipping ends to be located downwardly and submerged in fluid when the device is placed on its side in a reactive position. The position stabilizer may comprise a sidewall indentation that reduces the internal volume of the cup and keeps the cup from rolling when placed on its side.

4977077, Dec 11, 1990

Apr 25, 1988

7/185218

That T. Ngo - Irvine CA
Raphael C. Wong - Irvine CA

Bioprobe International - Tustin CA

C12Q 100

435 7

The presence of an antigenic analyte ligand in a liquid sample is determined by (1) mixing the sample with a fluorescently labeled ligand immunologically complexed onto a solid phase supported antibody capable of exchanging the fluorescently labeled ligand with the analyte ligand in the sample and (2) measuring the fluorescence of the resulting liquid phase without measuring the fluorescence of the resulting solid phase and without separating the resulting solid phase from the resulting liquid phase.